Equity · Healthcare
BRKRP
Bruker Corporation · NasdaqGS
The line runs $442 on 30 June through $439.87 on 23 September, on a scale from $375 to $475. Days the market did not trade hold the previous close, flat.
The chart above plots the price of BRKRP over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 31 sessions over that window: $442 on 30 June 2026 through $439.87 on 23 September 2026.
Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 23, 2026
Filings 4 sets
BRKRP reported financials
BRKRP reported revenue of $3.4B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$8.6M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
BRKRP earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
BRKRP institutional holders
3 of the 45 institutional funds we track reported a BRKRP position for the quarter ended 30 Jun 2026 — a combined $131.5M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings
BRKRP fails-to-deliver
On 19 Aug 2026, 44 shares of BRKRP failed to deliver (about $18K) — the latest of 3 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data